(Circulation. 1997;96:2178-2182.)
© 1997 American Heart Association, Inc.
Articles |
Anti-Ischemic and Anti-Anginal Effects of Thoracic Epidural Anesthesia Versus Those of Conventional Medical Therapy in the Treatment of Severe Refractory Unstable Angina Pectoris
From the Department of Anesthesia and Intensive Care (K.O., H.M., S.-E.R.), and the Department of Cardiology (L.L., B.W., H.E.), Sahlgrenska University Hospital, Göteborg, Sweden.
Correspondence to Sven-Erik Ricksten, MD, PhD, Department of Anesthesia and Intensive Care, Sahlgrenska University Hospital, S-413 45 Göteborg, Sweden.
Background Cardiac sympathetic blockade by thoracic epidural anesthesia (TEA) dilates stenotic coronary arteries and has been used to control pain in patients with unstable angina. The aim of the present study was to evaluate the potential anti-ischemic effects of cardiac sympathetic blockade by TEA in severe, refractory, unstable angina.
Methods and Results Forty patients with unstable angina refractory to standard anti-anginal therapy were randomized to receive either continuous epidural infusion of bupivacaine (TEA, Th1 to Th5) or to standard anti-anginal therapy including ß-blockers, calcium antagonists, aspirin, heparin, and nitroglycerin infusion (control group). The primary end points were number of anginal attacks and severity of myocardial ischemia assessed by 48-hour ambulatory Holter monitoring. The incidence of myocardial ischemia was lower in the TEA group (22% versus 61%; P<.05). The number of ischemic episodes per patient was 1.0±0.6 in the TEA group and 3.6±0.9 in the control group (P<.05). The episode duration per patient was 4.1±2.5 minutes and 19.7±6.2 minutes in the TEA and the control groups, respectively (P<.05). The mean area-under-the-ST-time-curve was 6.8±4.3 and 32.2±14.3 (mm · min) in the TEA and the control groups, respectively (P<.05). Fifteen anginal attacks were recorded in the control group and one attack in the TEA group (0.83±0.21 versus 0.06±0.06/patient, respectively, P<.01).
Conclusions The anti-ischemic and anti-anginal effects of continuous TEA are superior to those of conventional therapy in the treatment of refractory unstable angina.
Key Words: angina • ischemia • anesthesia • nervous system • autonomic • electrocardiography
This article has been cited by other articles:
 |
|
 |
|
  P.-G. Chassot, A. Delabays, and D. R. Spahn Perioperative antiplatelet therapy: the case for continuing therapy in patients at risk of myocardial infarction Br. J. Anaesth., September 1, 2007; 99(3): 316 - 328. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. C. Mineo Epidural anesthesia in awake thoracic surgery Eur. J. Cardiothorac. Surg., July 1, 2007; 32(1): 13 - 19. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Suttner, K. Lang, S. N. Piper, H. Schultz, K. D. Rohm, and J. Boldt Continuous Intra- and Postoperative Thoracic Epidural Analgesia Attenuates Brain Natriuretic Peptide Release After Major Abdominal Surgery Anesth. Analg., September 1, 2005; 101(3): 896 - 903. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Schmidt, F. Hinder, H. Van Aken, G. Theilmeier, C. Bruch, S. P. Wirtz, H. Burkle, T. Guhs, M. Rothenburger, and E. Berendes The Effect of High Thoracic Epidural Anesthesia on Systolic and Diastolic Left Ventricular Function in Patients with Coronary Artery Disease Anesth. Analg., June 1, 2005; 100(6): 1561 - 1569. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Nygard, K. F. Kofoed, J. Freiberg, S. Holm, J. Aldershvile, K. Eliasen, and H. Kelbaek Effects of High Thoracic Epidural Analgesia on Myocardial Blood Flow in Patients With Ischemic Heart Disease Circulation, May 3, 2005; 111(17): 2165 - 2170. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Svorkdal Treatment of Inoperable Coronary Disease and Refractory Angina: Spinal Stimulators, Epidurals, Gene Therapy, Transmyocardial Laser, and Counterpulsation Seminars in Cardiothoracic and Vascular Anesthesia, March 1, 2004; 8(1): 43 - 58. [Abstract] [PDF]
|
|
|
|
 |
|
 E. Berendes, C. Schmidt, H. Van Aken, M. G. Hartlage, S. Wirtz, H. Reinecke, M. Rothenburger, H. H. Scheld, B. Schluter, G. Brodner, et al. Reversible Cardiac Sympathectomy by High Thoracic Epidural Anesthesia Improves Regional Left Ventricular Function in Patients Undergoing Coronary Artery Bypass Grafting: A Randomized Trial Arch Surg, December 1, 2003; 138(12): 1283 - 1290. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Aybek, P. Kessler, S. Dogan, G. Neidhart, M. F. Khan, G. Wimmer-Greinecker, and A. Moritz Awake coronary artery bypass grafting: utopia or reality? Ann. Thorac. Surg., April 1, 2003; 75(4): 1165 - 1170. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. A. de Leon-Casasola When It Comes to Outcome, We Need to Define What a Perioperative Epidural Technique Is Anesth. Analg., February 1, 2003; 96(2): 315 - 318. [Full Text] [PDF]
|
|
|
|
|
|
M. Huikeshoven, J. F. Beek, J. A.P. van der Sloot, R. Tukkie, J. van der Meulen, and M. J.C. van Gemert 35 years of experimental research in transmyocardial revascularization: what have we learned? Ann. Thorac. Surg., September 1, 2002; 74(3): 956 - 970. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Mannheimer, P. Camici, M.R. Chester, A. Collins, M. DeJongste, T. Eliasson, F. Follath, I. Hellemans, J. Herlitz, T. Luscher, et al. The problem of chronic refractory angina. Report from the ESC Joint Study Group on the Treatment of Refractory Angina Eur. Heart J., March 1, 2002; 23(5): 355 - 370. [Full Text] [PDF]
|
|
|
|
|
|
M. C. Priestley, L. Cope, R. Halliwell, P. Gibson, R. B. Chard, M. Skinner, and P. L. Klineberg Thoracic Epidural Anesthesia for Cardiac Surgery: The Effects on Tracheal Intubation Time and Length of Hospital Stay Anesth. Analg., February 1, 2002; 94(2): 275 - 282. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Jin and F. Chung Minimizing perioperative adverse events in the elderly{dagger} Br. J. Anaesth., October 1, 2001; 87(4): 608 - 624. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Blomberg, S.-E. Ricksten, K. Olausson, H. Magnusdottir, L. Lurje, B. Wennerblom, and H. Emanuelsson Can the Results be Explained by Poor Randomization and Nonpertinent Comparisons? • Response Circulation, April 11, 2000; 101 (14): e162 - e162. [Full Text] [PDF]
|
|
|
|
 |
|
 G. Hasenfuss Animal models of human cardiovascular disease, heart failure and hypertrophy Cardiovasc Res, July 1, 1998; 39(1): 60 - 76. [Abstract] [Full Text] [PDF]
|
|